DZ BANK/CALL/APOS PHAR/6/1/20.09.24 Stock

DZ BANK/CALL/APOS PHAR/6/1/20.09.24 Share Price

DE000DJ894Y3

Market Closed - Boerse Frankfurt Warrants 01:04:54 09/07/2024 am IST
2.71 ^EUR	+4.23%

Current month	+7.97%
1 month	-6.87%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart APONTIS PHARMA AG

Chart DZ BANK/CALL/APOS PHAR/6/1/20.09.24

Latest news about APONTIS PHARMA AG

APONTIS PHARMA AG appoints CFO Thomas Zimmermann to the Management Board with a view to the strategic development of the Company	27/06	EQ
Apontis Pharma AG Appoints Thomas Zimmermann to the Management Board, Effective 1 July 2024	27/06	CI
APONTIS PHARMA continues to gear organization towards growth and internationalization – Renowned industry expert leads supply chain management	04/06	EQ
DD: APONTIS PHARMA AG: Thomas Milz, buy	14/05	EQ

More news

Quotes 5-day view

Date	Price	Change
08/24/08	2.71	+4.23%
05/24/05	2.6	+10.64%
04/24/04	2.35	+2.17%
03/24/03	2.3	-0.86%
02/24/02	2.32	-7.20%

Real-time Boerse Frankfurt Warrants

Last update July 09, 2024 at 01:04 am IST

More quotes

Static data

Product type	Warrants
Buy / Sell	CALL
Underlying	APONTIS PHARMA AG
Issuer	DZ BANK
WKN	DJ894Y
ISIN	DE000DJ894Y3
Date issued	07/02/2024
Strike	6 €
Maturity	20/09/2024 (74 Days)
Parity	1 : 1
Emission price	1.2 €
Emission volume	N/A
Settlement	règlement en espèces
Currency	EUR

Technical Indicators

Highest since issue	3.81 €
Lowest since issue	0.84 €
Delta	0.9x
Omega	2.616
Premium	2.38x
Gearing	2.9x
Moneyness	1.473
Difference Strike	-2.84 €
Difference Strike %	-47.33%
Spread	0.68 €
Spread %	20.06%
Theoretical value	3.045
Implied Volatility	77.47 %
Total Loss Probability	16.92 %
Intrinsic value	2.840
Present value	0.2050
Break even	9.045 €
Theta	-0.03x
Vega	0.01x
Rho	0.01x

Company Profile

Apontis Pharma AG is a Germany-based manufacturer of pharmaceutical preparation. The company focuses on the commercialization of pharmaceutical products to General Practitioners and engages in the marketing and sale of medical drugs for indication fields of internal medicine in Germany.

Sector

More about the company